Leuprolide in the treatment of endometrial cancer (multiple letters)

Gynecologic Oncology

Volumn 66, Issue 3, 1997, Pages 542-

  Markman, M ^a   Kennedy, A ^a   Webster, K ^a   Peterson, G ^a   Kulp, B ^a   Belinson, J ^a   Covens, A ^a   Thomas, G ^a   Shaw, P ^a   Ackerman, I ^a   Osborne, R ^a   Lukka, H ^a   Carey, M ^a   Franssen, E ^a   Roche, K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST; LEUPRORELIN;

ADULT; AGED; CANCER GRADING; CANCER RECURRENCE; CLINICAL ARTICLE; DRUG EFFECT; DRUG TOLERABILITY; ENDOMETRIUM CANCER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; LETTER; PRIORITY JOURNAL; PUBLICATION;

EID: 0030930435     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4767     Document Type: Editorial

References (1)

1. A Covens G Thomas P Shaw I Ackerman R Osborne H Lukka M Carey E Franssen K Roche A phase II study of leuprolide in advanced/recurrent endometrial cancer Gynecol Oncol 64 1997 126 129